Top Suppliers:I want be here



13292-22-3

13292-22-3 structure
13292-22-3 structure
  • Name: 3-Formyl Rifamycin
  • Chemical Name: 3-Formyl Rifamycin
  • CAS Number: 13292-22-3
  • Molecular Formula: C38H47NO13
  • Molecular Weight: 725.779
  • Catalog: API Antibiotics Rifamycin
  • Create Date: 2018-02-09 08:00:00
  • Modify Date: 2024-01-02 18:08:55
  • 3-Formyl rifamycin is an intermediate of Rifampicin.

Name 3-Formyl Rifamycin
Synonyms (7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-26-Formyl-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1.0]triaconta-1( 
29),2,4,9,19,21,25,27-octaen-13-yl acetate
(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-26-Formyl-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1.0]triaconta-1(28),2,4,9,19,21,25(29),26-octaen-13-yl acetate
2,7-(Epoxy[1,11,13]pentadecatrienoimino)naphtho[2,1-b]furan-8-carboxaldehyde, 21-(acetyloxy)-1,2-dihydro-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-, (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-
3-Formylrifamycin
Description 3-Formyl rifamycin is an intermediate of Rifampicin.
Related Catalog
Density 1.4±0.1 g/cm3
Boiling Point 855.4±65.0 °C at 760 mmHg
Melting Point 182-184°C
Molecular Formula C38H47NO13
Molecular Weight 725.779
Flash Point 471.1±34.3 °C
Exact Mass 725.304749
PSA 218.38000
LogP 2.85
Vapour Pressure 0.0±0.3 mmHg at 25°C
Index of Refraction 1.633
Storage condition -20°C Freezer, Under Inert Atmosphere

CHEMICAL IDENTIFICATION

RTECS NUMBER :
KD1600000
CHEMICAL NAME :
2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b) furan-8-carboxaldehyd e, 1,2-dihydro-5, 6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,2 2-heptamethyl-1,11-di oxo-, 21-acetate
CAS REGISTRY NUMBER :
13292-22-3
LAST UPDATED :
199703
DATA ITEMS CITED :
3
MOLECULAR FORMULA :
C38-H47-N-O13
MOLECULAR WEIGHT :
725.86

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
907 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #4002754
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
416 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #4002754
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
299 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
38KLAC "Structure-Activity Relationship among the Semisynthetic Antibiotics," Perlman, D., ed., New York, Academic Press, 1977 Volume(issue)/page/year: -,531,1977

~88%

13292-22-3 structure

13292-22-3

Literature: Pyta, Krystian; Przybylski, Piotr; Wicher, Barbara; Gdaniec, Maria; Stefanska, Joanna Organic and Biomolecular Chemistry, 2012 , vol. 10, # 12 p. 2385 - 2388